Literature DB >> 25052009

The role of CD4(+) T cells in BKV-specific T cell immunity.

B J D Weist1, M Schmueck, H Fuehrer, A Sattler, P Reinke, N Babel.   

Abstract

Reactivation of polyomavirus BK (BKV) infection represents a severe complication in kidney transplant (KTX) patients. We previously reported an association between a declining BK viral load and the reconstitution of CD4(+) T cell BKV-specific immunity in patients following kidney transplantation. However, the specific contribution of CD4(+) T cells in the regulation of BKV-replication is unknown. Nevertheless, in vitro enrichment of BKV-specific T cells and subsequent adoptive T cell transfer may improve the restoration of immune competence in KTX patients with BKV infection. To date, strategies to capture human BKV-specific T cells with the ensuing expansion to clinically useful numbers are lacking. Here, we demonstrated a comprehensive flow cytometric analysis of the BKV-specific T cell response that permits access to the majority of T cells specific for immunodominant BKV antigens. A full-spectrum evaluation of the BKV-specific T cell response was performed by stimulating peripheral blood mononuclear cells (PBMC) with a mixture of BKV immunodominant peptide pools at varying concentrations and measuring activation marker expression and cytokine secretion. We also examined the effects of co-stimulation and PBMC resting time prior to activation. We defined the narrow range of stimulation conditions that permit the capture and expansion of functional BKV-specific T cell lines. The generated BKV-specific T cell lines showed the highest specificity and functionality when the T cells were captured according to IFNγ-secretion. This study highlights the multifunctional and cytolytic BKV-specific CD4(+) T cells as a dominant population within the generated T cell product. This method offers a novel approach for the generation of BKV-specific T cell lines for adoptive immunotherapy and underscores the critical role of CD4(+) T cells in the clearance of BKV.

Entities:  

Mesh:

Year:  2014        PMID: 25052009     DOI: 10.1007/s00430-014-0348-z

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  56 in total

1.  Preculture of PBMCs at high cell density increases sensitivity of T-cell responses, revealing cytokine release by CD28 superagonist TGN1412.

Authors:  Paula S Römer; Susanne Berr; Elita Avota; Shin-Young Na; Manuela Battaglia; Ineke ten Berge; Hermann Einsele; Thomas Hünig
Journal:  Blood       Date:  2011-09-19       Impact factor: 22.113

2.  BK virus-specific T cells for use in cellular therapy show specificity to multiple antigens and polyfunctional cytokine responses.

Authors:  Emily Blyth; Leighton Clancy; Renee Simms; Shivashni Gaundar; Philip O'Connell; Kenneth Micklethwaite; David J Gottlieb
Journal:  Transplantation       Date:  2011-11-27       Impact factor: 4.939

3.  Cutting edge: MHC class II-restricted killing in vivo during viral infection.

Authors:  Evan R Jellison; Sung-Kwon Kim; Raymond M Welsh
Journal:  J Immunol       Date:  2005-01-15       Impact factor: 5.422

4.  Adoptive cellular therapy for cytomegalovirus infection following allogeneic stem cell transplantation using virus-specific T cells.

Authors:  Stephen Mackinnon; Kirsty Thomson; Stephanie Verfuerth; Karl Peggs; Mark Lowdell
Journal:  Blood Cells Mol Dis       Date:  2007-09-14       Impact factor: 3.039

5.  CD134 plus CD137 dual costimulation induces Eomesodermin in CD4 T cells to program cytotoxic Th1 differentiation.

Authors:  Harry Z Qui; Adam T Hagymasi; Suman Bandyopadhyay; Marie-Clare St Rose; Raghunath Ramanarasimhaiah; Antoine Ménoret; Robert S Mittler; Scott M Gordon; Steven L Reiner; Anthony T Vella; Adam J Adler
Journal:  J Immunol       Date:  2011-08-31       Impact factor: 5.422

6.  Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease.

Authors:  Laurent Monney; Catherine A Sabatos; Jason L Gaglia; Akemi Ryu; Hanspeter Waldner; Tatyana Chernova; Stephen Manning; Edward A Greenfield; Anthony J Coyle; Raymond A Sobel; Gordon J Freeman; Vijay K Kuchroo
Journal:  Nature       Date:  2002-01-31       Impact factor: 49.962

Review 7.  BK polyomavirus infection and nephropathy: the virus-immune system interplay.

Authors:  Nina Babel; Hans-Dieter Volk; Petra Reinke
Journal:  Nat Rev Nephrol       Date:  2011-05-24       Impact factor: 28.314

8.  OX40 promotes Bcl-xL and Bcl-2 expression and is essential for long-term survival of CD4 T cells.

Authors:  P R Rogers; J Song; I Gramaglia; N Killeen; M Croft
Journal:  Immunity       Date:  2001-09       Impact factor: 31.745

9.  The VITAL assay: a versatile fluorometric technique for assessing CTL- and NKT-mediated cytotoxicity against multiple targets in vitro and in vivo.

Authors:  Ian F Hermans; Jonathan D Silk; Jianping Yang; Michael J Palmowski; Uzi Gileadi; Corinna McCarthy; Mariolina Salio; Franca Ronchese; Vincenzo Cerundolo
Journal:  J Immunol Methods       Date:  2004-02-01       Impact factor: 2.303

10.  Generation of HCMV-specific T-cell lines from seropositive solid-organ-transplant recipients for adoptive T-cell therapy.

Authors:  Gordon Brestrich; Sandra Zwinger; Andy Roemhild; Michel Noutsias; Maria Rohde; Kathrin Keeren; Birgit Sawitzki; Hans-Dieter Volk; Petra Reinke; Markus H Hammer
Journal:  J Immunother       Date:  2009 Nov-Dec       Impact factor: 4.456

View more
  12 in total

1.  A revised strategy for monitoring BKV-specific cellular immunity in kidney transplant patients.

Authors:  Benjamin J D Weist; Patrizia Wehler; Linda El Ahmad; Michael Schmueck-Henneresse; Jason M Millward; Mikalai Nienen; Avidan U Neumann; Petra Reinke; Nina Babel
Journal:  Kidney Int       Date:  2015-07-29       Impact factor: 10.612

2.  Early identification of renal transplant recipients with high risk of polyomavirus-associated nephropathy.

Authors:  K Teutsch; F Schweitzer; E Knops; R Kaiser; H Pfister; J Verheyen; H Göbel; T Cingöz; V Di Cristanziano
Journal:  Med Microbiol Immunol       Date:  2015-03-07       Impact factor: 3.402

Review 3.  BK Polyomavirus: Clinical Aspects, Immune Regulation, and Emerging Therapies.

Authors:  George R Ambalathingal; Ross S Francis; Mark J Smyth; Corey Smith; Rajiv Khanna
Journal:  Clin Microbiol Rev       Date:  2017-04       Impact factor: 26.132

4.  Increased frequency of JC-polyomavirus detection in rheumatoid arthritis patients treated with multiple biologics.

Authors:  Jens Verheyen; Kseniya Maizus; Eugen Feist; Zebulon Tolman; Elena Knops; Jasemine Saech; Lydia Spengler; Tim Waterboer; Gerd R Burmester; Michael Pawlita; Herbert Pfister; Andrea Rubbert-Roth
Journal:  Med Microbiol Immunol       Date:  2015-02-13       Impact factor: 3.402

5.  Association of donor hepatitis C virus infection status and risk of BK polyomavirus viremia after kidney transplantation.

Authors:  Miklos Z Molnar; Vishnu S Potluri; Douglas E Schaubel; Meghan E Sise; Beatrice P Concepcion; Rachel C Forbes; Emily Blumberg; Roy D Bloom; David Shaffer; Raymond T Chung; Ian A Strohbehn; Nahel Elias; Ambreen Azhar; Mital Shah; Deirdre Sawinski; Laura A Binari; Manish Talwar; Vasanthi Balaraman; Anshul Bhalla; James D Eason; Behdad Besharatian; Jennifer Trofe-Clark; David S Goldberg; Peter P Reese
Journal:  Am J Transplant       Date:  2021-10-06       Impact factor: 8.086

6.  SARS-CoV-2-specific T cell responses and correlations with COVID-19 patient predisposition.

Authors:  Arne Sattler; Stefan Angermair; Helena Stockmann; Katrin Moira Heim; Dmytro Khadzhynov; Sascha Treskatsch; Fabian Halleck; Martin E Kreis; Katja Kotsch
Journal:  J Clin Invest       Date:  2020-12-01       Impact factor: 14.808

7.  Detection of pre-existing SARS-CoV-2-reactive T cells in unexposed renal transplant patients.

Authors:  Moritz Anft; Arturo Blazquez-Navarro; Ulrik Stervbo; Sarah Skrzypczyk; Oliver Witzke; Rainer Wirth; Mira Choi; Christian Hugo; Petra Reinke; Toni Luise Meister; Eike Steinmann; Stephanie Pfaender; Peter Schenker; Richard Viebahn; Timm H Westhoff; Nina Babel
Journal:  J Nephrol       Date:  2021-07-06       Impact factor: 3.902

Review 8.  BK nephropathy in the native kidneys of patients with organ transplants: Clinical spectrum of BK infection.

Authors:  Darlene Vigil; Nikifor K Konstantinov; Marc Barry; Antonia M Harford; Karen S Servilla; Young Ho Kim; Yijuan Sun; Kavitha Ganta; Antonios H Tzamaloukas
Journal:  World J Transplant       Date:  2016-09-24

9.  Characterization of Immunodominant BK Polyomavirus 9mer Epitope T Cell Responses.

Authors:  M Cioni; C Leboeuf; P Comoli; F Ginevri; H H Hirsch
Journal:  Am J Transplant       Date:  2016-02-17       Impact factor: 8.086

10.  Immune monitoring facilitates the clinical decision in multifocal COVID-19 of a pancreas-kidney transplant patient.

Authors:  Nina Babel; Moritz Anft; Arturo Blazquez-Navarro; Adrian A N Doevelaar; Felix S Seibert; Frederic Bauer; Benjamin J Rohn; Bodo Hoelzer; Constantin J Thieme; Toralf Roch; Toni L Meister; Stephanie Pfaender; Eike Steinmann; Ulf Dittmer; Peter Schenker; Kerstin Amann; Richard Viebahn; Ulrik Stervbo; Timm H Westhoff
Journal:  Am J Transplant       Date:  2020-09-09       Impact factor: 9.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.